53.99

4.16% 2.298

Spruce Biosciences Inc (SPRB)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

$51.69

Aprire:

$56.75

Volume 24 ore:

126.17K

Relative Volume:

2.27

Capitalizzazione di mercato:

$73.42M

Reddito:

$697.00K

Utile/perdita netta:

$-38.97M

Rapporto P/E:

-1.8569

EPS:

-29.075

Flusso di cassa netto:

$-33.33M

1 W Prestazione:

-22.33%

1M Prestazione:

-7.81%

6M Prestazione:

-61.69%

1 anno Prestazione:

-90.34%

Intervallo 1D:

$53.43

$56.75

Intervallo di 1 settimana:

$51.36

$74.00

Portata 52W:

$7.26

$543.38

Spruce Biosciences Inc Stock (SPRB) Company Profile

Nome

Spruce Biosciences Inc

Settore

Healthcare (1113)

Industria

Biotechnology (624)

Telefono

(415) 655-4168

Indirizzo

611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO

Dipendente

Cinguettio

Prossima data di guadagno

2026-05-05

Ultimi documenti SEC

SPRB's Discussions on Twitter

Compare SPRB vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SPRB Spruce Biosciences Inc	53.50	70.93M	697.00K	-38.97M	-33.33M	-29.07
VRTX Vertex Pharmaceuticals Inc	436.94	111.05B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	744.29	79.01B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	795.51	50.08B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	310.21	41.15B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	311.22	34.67B	5.36B	287.73M	924.18M	2.5229

Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-23	Iniziato	Oppenheimer	Outperform
2025-12-03	Aggiornamento	Leerink Partners	Market Perform → Outperform
2025-10-28	Aggiornamento	Citizens JMP	Mkt Perform → Mkt Outperform
2024-12-11	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2024-12-11	Downgrade	Oppenheimer	Outperform → Perform
2024-03-14	Downgrade	Guggenheim	Buy → Neutral
2024-03-14	Downgrade	H.C. Wainwright	Buy → Neutral
2024-03-14	Downgrade	Ladenburg Thalmann	Buy → Neutral
2024-03-14	Downgrade	Leerink Partners	Outperform → Market Perform
2024-03-14	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2024-02-21	Iniziato	Guggenheim	Buy
2021-12-17	Iniziato	Oppenheimer	Outperform
2021-12-10	Iniziato	The Benchmark Company	Speculative Buy
2021-11-16	Downgrade	SVB Leerink	Outperform → Mkt Perform
2021-07-19	Iniziato	H.C. Wainwright	Buy
2021-04-26	Ripresa	Credit Suisse	Outperform
2020-11-03	Iniziato	Cowen	Outperform
2020-11-03	Iniziato	Credit Suisse	Outperform
2020-11-03	Iniziato	RBC Capital Mkts	Outperform
2020-11-03	Iniziato	SVB Leerink	Outperform

Mostra tutto

Spruce Biosciences Inc Borsa (SPRB) Ultime notizie

08:05 AM

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

08:05 AM

07:17 AM

SPRB Spruce Biosciences Inc. gains 3.53 percent even as Q4 2025 earnings miss analyst consensus estimates.Recovery Report - Xã Thanh Hà

07:17 AM

06:48 AM

Spruce Biosciences Prices Equity Offering to Raise Capital - TipRanks

06:48 AM

06:03 AM

Spruce Biosciences Enters Underwriting For $69 Million Equity Offering; Option Fully Exercised - TradingView

06:03 AM

Apr 21, 2026

Spruce Biosciences prices $60M public offering at $50.00 per share - MSN

Apr 21, 2026

Spruce Biosciences (NASDAQ: SPRB) raises about $69.0 million in equity sale - Stock Titan

Apr 21, 2026

Spruce Biosciences (NASDAQ: SPRB) sells 1.15M shares, issues pre-funded warrants - Stock Titan

Apr 21, 2026

Spruce Biosciences prices $60M public offering at $50 per share By Investing.com - Investing.com South Africa

Apr 21, 2026

Stock Market Today: Dow Jones, S&P 500 Futures Edge Higher With Eyes On Iran Talks—Apple, UnitedHealth, 3M In Focus - Benzinga

Apr 21, 2026

Why Amazon Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 21, 2026

Spruce Biosciences locks in $60M raise at $50 a share - Stock Titan

Apr 21, 2026

Spruce Biosciences Prices Public Offering of Common Stock, Prefunded Warrants>SPRB - Moomoo

Apr 21, 2026

Spruce Biosciences (SPRB) Announces $60 Million Public Offering - GuruFocus

Apr 21, 2026

Spruce Biosciences Offering Expected to Close April 22 >SPRB - Moomoo

Apr 21, 2026

Spruce Biosciences launches public stock offering By Investing.com - Investing.com India

Apr 21, 2026

Spruce Biosciences Expects Gross Proceeds of $60M >SPRB - Moomoo

Apr 21, 2026

Spruce Biosciences prices $60M public offering at $50 per share - Investing.com Canada

Apr 21, 2026

Apr 20, 2026

Spruce Biosciences Announces Pricing Of Public Offering Of Common Stock And Pre-Funded Warrants - TradingView

Apr 20, 2026

Spruce Biosciences Begins Public Offering of Stock, Prefunded Warrants; Shares Fall After Hours - Moomoo

Apr 20, 2026

Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - The National Law Review

Apr 20, 2026

Spruce Biosciences announces proposed public offering of common stock, pre-funded warrants - MSN

Apr 20, 2026

Spruce Biosciences (SPRB) Sees 13% Drop Following Equity Offerin - GuruFocus

Apr 20, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 20, 2026

Spruce Biosciences launches public stock offering - Investing.com

Apr 20, 2026

Spruce Biosciences Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants - TradingView

Apr 20, 2026

Spruce Biosciences (SPRB) seeks capital with common stock and pre-funded warrants offering - Stock Titan

Apr 20, 2026

Apr 16, 2026

SPRB Technical Analysis | Trend, Signals & Chart Patterns | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill

Apr 16, 2026

Apr 10, 2026

Top Anthem (ANTX) Competitors 2026 - MarketBeat

Apr 10, 2026

SPRB Stock Price, Quote & Chart | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill

Apr 10, 2026

Apr 09, 2026

Spruce Biosciences (NASDAQ: SPRB) sets 2026 virtual meeting and pay votes - Stock Titan

Apr 09, 2026

Apr 08, 2026

SPRB SEC FilingsSpruce Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 08, 2026

Apr 03, 2026